West Midlands Academic Health Science Network
Tony Davis
West Midlands AHSN
Background
• Innovation, Health & Wealth – published December 11 set out a plan for spreading innovation through the NHS
• Focus that innovation is vital in order to transform healthcare
• Aim to rapidly spread change to improve quality, safety and productivity
Role and purpose of AHSNs
• Improve the identification, adoption, spread, speed of innovation and good practice in the NHS
• Provide the opportunity to align education and training, clinical research, informatics, innovation and healthcare delivery
• Enable the NHS and academia to work collaboratively with industry
• Overall purpose to improve patient outcomes and create wealth
• Succeed where others have not
West Midlands - background
• 5.6m diverse population• Inequality in health outcomes and healthcare delivery• Academic & clinical excellence, established regional
networks and collaborations • Industrial heritage that will drive wealth creation
WM AHSN aims
• To transform the identification, adoption and spread of innovation and good practice
• To align healthcare delivery, research, education and training
• To drive wealth creation through the development of a regional industry portal enabling access to the NHS, driving adoption and publishing evaluation
• To improve outcomes
Strategy & vision – 6 enabling themes• Develop a novel and comprehensive digital framework• Establish regional clinical trials platforms - support for
acceleration, reducing bureaucracy, improving efficiency and cost effectiveness
• To promote and accelerate innovation, evaluation and adoption
• To drive and develop patient-centric integrated care pathways - bridging primary, secondary & social care
• Focus on education & training - delivering a fit for purpose workforce in partnership with HEWM
• To create wealth - proactive support for regional medical technology industry engagement
Initial focus on 3 clinical priorities
• Mental health– In the young – Dementia (carers, community management)
• Long Term Conditions– Diabetes & obesity– Musculoskeletal disease
• Drug safety– From hospital to primary care– Reducing prescribing errors across the region
Organisations involved in AHSN development to date
• University Hospitals Coventry and Warwickshire NHS Trust• University Hospitals Birmingham NHS Foundation Trust• University of Birmingham• Keele University• Birmingham and Solihull Mental Health Foundation Trust• University Hospital North Staffordshire NHS Trust• University of Warwick• Heart of England NHS Foundation Trust• West Midlands South CLRN • Medilink West Midlands
Organisation & governance
MEMBERS
ownership and overall responsibility
for the AHSN
STAKEHOLDERS & PARTNERS
sector cohesion via stakeholder
reference groups
BOARD
leadership, strategy &
assurance Independent Chair
EXECUTIVE
responsibility for the execution and
delivery of the strategy
AHSN board
• Chair • MD• COO• Spoke chairs x 3• HEIs x 3• MH / community trust CEO• Commercial representative • LETB (non voting) • CRN (non voting)
AHSN
Commissioning and Senate Reference
Group
Patients and Carers
Reference Group
Wider Stakeholder Group - LA, 3rd
Sector
Commercial & Industry
Reference Group
Current position
• Designated without condition on 13th May 2013 (7 of the 15 AHSNs had conditions)
• £5.09 million funding for 2013/14 – given in two parts• Ensuring organisational form is fit for purpose with
processes, structures and governance in place in order to be effective
• Stakeholder events for each theme and each spoke • Defining our programmes of work and deliverables for
each theme
“It must be remembered that there is nothing more difficult to plan, more doubtful of success, nor more difficult to manage than a new system. For the initiator has the challenge of all who would profit by the preservation of the old institution and merely lukewarm defenders in those who gain by the new ones. ”
Machiavelli
Our hope 5 years on…
• To have an integrated & innovative health network – not just in words
• To be the first UK regional digital healthcare economy • To be the known place for industry for NHS access,
evaluation and adoption• To be significantly on the road to reversing health
inequality and to have significantly improved outcomes for the region
“It is not the strongest or the most intelligent who will survive but those who can best
manage change.”
Charles Darwin
Questions?